Is MDCLF or PLD a better dividend investment in 2026?

MDCLF currently yields 5.82% with a 5% 5-year dividend growth rate. PLD yields 3.18% with 5% growth. The better choice depends on your goal: MDCLF offers higher current income.

What is the dividend yield difference between MDCLF and PLD?

MDCLF has a forward dividend yield of 5.82% ($2.00/share annually). PLD yields 3.18% ($4.10/share annually). The yield gap is 2.64 percentage points.

Home › Compare › MDCLF vs PLD

MDCLF vs PLD: Dividend Comparison 2026

MDCLF yields 5.82% · PLD yields 3.18%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 PLD wins by $6.47M in total portfolio value· pulled ahead in Year 2

INVESTMENT

TIME HORIZON10 years

MDCLF

● Live price

5.82%

Share price

$34.39

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$29.3K

Annual income

$842.73

Full MDCLF calculator →

PLD

● Live price

3.18%

Share price

$128.78

Annual div

$4.10

5Y div CAGR

74.4%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$6.50M

Annual income

$5,256,436.18

Full PLD calculator →

Portfolio growth — MDCLF vs PLD

📍 PLD pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MDCLF	PLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MDCLF + PLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MDCLF pays

PLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MDCLF

Annual income on $10K today (after 15% tax)

$494.33/yr

After 10yr DRIP, annual income (after tax)

$716.32/yr

PLD

Annual income on $10K today (after 15% tax)

$270.62/yr

After 10yr DRIP, annual income (after tax)

$4,467,970.75/yr

At 15% tax rate, PLD beats the other by $4,467,254.43/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MDCLF + PLD for your $10,000?

MDCLF: 50%PLD: 50%

100% PLD50/50100% MDCLF

Portfolio after 10yr

$3.27M

Annual income

$2,628,639.45/yr

Blended yield

80.47%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

MDCLF

Analyst Ratings

Buy

Consensus: Buy

Altman Z

5.5

Piotroski

5/9

PLD

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$136.00

+5.6% upside vs current

Range: $119.00 — $155.00

Altman Z

1.9

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MDCLF buys

PLD buys

No recent congressional trades found for MDCLF or PLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMDCLFPLD

Forward yield	5.82% ✓	3.18%
Annual dividend / share	$2.00	$4.10 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	74.4% ✓
Portfolio after 10y	$29.3K ✓	$6.50M
Annual income after 10y	$842.73	$5,256,436.18 ✓
Total dividends collected	$7.2K ✓	$6.37M
Payment frequency	quarterly	quarterly
Sector	Stock	REIT
Analyst consensus	Buy	Buy

Year-by-year: MDCLF vs PLD ($10,000, DRIP)

Year	MDCLF Portfolio	MDCLF Income/yr	PLD Portfolio	PLD Income/yr	Gap
1	$11,282	$581.56	$11,255	$555.24	+$27.00 → MDCLF
2← crossover	$12,684	$613.17	$13,062	$1,018.59	$378.00 → PLD
3	$14,217	$644.32	$15,903	$1,926.67	$1.7K → PLD
4	$15,887	$674.91	$20,839	$3,823.32	$5.0K → PLD
5	$17,704	$704.85	$30,464	$8,166.08	$12.8K → PLD
6	$19,677	$734.08	$52,054	$19,457.30	$32.4K → PLD
7	$21,817	$762.53	$109,886	$54,188.93	$88.1K → PLD
8	$24,134	$790.14	$304,030	$186,451.18	$279.9K → PLD
9	$26,641	$816.89	$1,166,125	$840,813.32	$1.14M → PLD
10	$29,348	$842.73	$6,504,190	$5,256,436.18	$6.47M → PLD

MDCLF vs PLD: Complete Analysis 2026

MDCLF — Stock

MedinCell S.A. develops various therapeutic solutions. It develops solutions based on BEPO, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceutical ingredients. The company's products in development include mdc-IRM, a subcutaneous injection in Phase III trials for use in the treatment of schizophrenia; mdc-CWM, an intra-articular injection to treat pain and inflammation; and mdc-TJK, a subcutaneous injection in preclinical trials for use in the treatment of schizophrenia. Its product candidates in formulation research comprise subcutaneous injections, such as mdc-WWM for contraception; mdc-ANG for CNS related treatments; mdc-ELK for depression; and mdc-GRT for use in organ transplant, as well as perineural injections, including mdc-CMV for anesthesia and pain, and mdc-NVA for pain. The company is based in Jacou, France.

Full MDCLF Calculator →

PLD — REIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →

📬

Get this MDCLF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MDCLF vs SCHD MDCLF vs JEPI MDCLF vs O MDCLF vs KO MDCLF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.